Publications: Sequential Monitoring of Tumor Marker Status During Therapy

• SABCS 2023: Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer

• ASCO 2023:  Sequential monitoring of tumor macrophage fusion cells in the circulation of metastatic breast cancer and their prognostic value

• Tri-Con 2019: Changes in the type of circulating cancer associated macrophage-like cells during and after radiation therapy is associated with progression in thoracic cancers

• Tri-Con 2019: Real time monitoring of solid tumor progression using circulating stromal cells in early and late stage disease

• Sequential tracking of PD-L1 expression and RAD50 induction in circulating tumor and stromal cells of lung cancer patients undergoing radiotherapy

  Adams DL, Adams DK, He J, Kalhor N, Zhang M, Xu T, Gao H, Reuben JM, Qiao Y, Komaki R, Liao Z, Edelman MJ, Tang C-M, Lin SH. Clinical Cancer Research, Published OnlineFirst August 16, 2017 DOI: 10.1158/1078-0432.CCR-17-0802